News
2h
HealthDay on MSNGLP-1 Receptor Agonists May Reduce Complications of Diabetic RetinopathyFor individuals with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a ...
7h
ScienceAlert on MSNScientists May Have Identified a Natural Alternative to OzempicGlucagon-like peptide-1 (GLP-1) is a hormone that is naturally produced by the body and which helps regulate blood sugar ...
18h
News-Medical.Net on MSNBrain’s energy control map offers blueprint for next-gen weight loss therapiesScientists map how the brain integrates hormonal and neural signals from the body to control appetite, energy use, and reward ...
(HealthDay News) — A considerable proportion of adolescents and young adults eligible for glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are uninsured, and many young adults do not have a ...
Accepting the bioequivalence study report, the Subject Expert Committee (SEC) functional under the Central Drugs Standard ...
Researchers at Syracuse University have identified a brain peptide, TDN, that effectively curbs appetite and enhances glucose ...
The new targeted pipeline will advance Nxera’s oral GLP-1 agonists, novel GPCR targets, and structure-based drug design to ...
Prices for Indian consumers are expected to come down significantly from the current Rs 17,000-Rs 26,000 monthly.
A UK government and Eli Lilly £85 million program will expand obesity care nationwide, offering digital, community, and ...
Data suggests that some sectors of Europe's confectionery sector are declining. Could GLP-1s have a role to play in this?
Fat jabs could soon be available over the counter at pharmacies without the need for a GP, according to rppeorts. Fat jabs ...
"Tirzepatide and other drugs like it, such as semaglutide, will help people living with obesity to lose weight, and as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results